Domain-specific cognitive impairment in patients with COPD and control subjects

International Journal of COPD

Volumn 12, Issue , 2016, Pages 1-11

  Cleutjens, Fiona A H M ^a   Franssen, Frits M E ^a   Spruit, Martijn A ^a   Vanfleteren, Lowie E G W ^a   Gijsen, Candy ^a   Dijkstra, Jeanette B ^b   Ponds, Rudolf W H M ^b   Wouters, Emiel F M ^a,c   Janssen, Daisy J A ^a  

^a Center of Expertise for Chronic Organ Failure   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cognitive domains; Cognitive functioning; Cognitive impairment; Comorbidities; COPD

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PLANNING; PREVALENCE; PSYCHOMOTOR PERFORMANCE; SCORING SYSTEM; SMOKING; VELOCITY; VERBAL MEMORY; WORKING MEMORY; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COGNITION; COGNITION DISORDERS; COST OF ILLNESS; LUNG; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PATHOPHYSIOLOGY; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COGNITION; COGNITION DISORDERS; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUNG; MALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PREVALENCE; PSYCHOMOTOR PERFORMANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 85007525392     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S119633     Document Type: Article

References (46)

1. Cleutjens FA, Janssen DJ, Ponds RW, Dijkstra JB, Wouters EF. COgnitive-pulmonary disease. BioMed Res Int. 2014;2014:697825.
2. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922.
3. Schou L, Østergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease – a systematic review. Respir Med. 2012;106(8):1071–1081.
4. Shrikrishna D, Hopkinson NS. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin Med (Lond). 2012;12(1):71–74.
5. Thakur N, Blanc PD, Julian LJ, et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruc Pulmon Dis. 2010;5:263–269.
6. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470–1476.
7. Barnes JN. Exercise, cognitive function, and aging. Adv Physiol Educ. 2015;39(2):55–62.
8. Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Ame J Epidemiol. 2007;166(4):367–378.
9. Evans DA, Beckett LA, Albert MS, et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol. 1993;3(1):71–77.
10. Cleutjens FA, Janssen DJ, Gijsen C, Dijkstra JB, Ponds RW, Wouters EF. [Cognitive impairment in patients with COPD: a review]. Cognitieve beperkingen bij patiënten met COPD: een overzicht. Tijdschr Gerontol Geriatr. 2014;45(1):1–9. Dutch.
11. Lahousse L, Tiemeier H, Ikram MA, Brusselle GG. Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review. Respir Med. 2015;109(11):1371–1380.
12. Kochunov P, Coyle T, Lancaster J, et al. Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging. Neuroimage. 2010;49(2):1190–1199.
13. Marchetta ND, Hurks PP, Krabbendam L, Jolles J. Interference control, working memory, concept shifting, and verbal fluency in adults with attention-deficit/hyperactivity disorder (ADHD). Neuropsychology. 2008;22(1):74–84.
14. Miller D. Best practices in school neuropsychology: Guidelines for effective practice, assessment, and evidenced-based intervention. Hoboken, NJ: John Wiley and Sons.
15. Leber AB, Turk-Browne NB, Chun MM. Neural predictors of moment-to-moment fluctuations in cognitive flexibility. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(36):13592–13597.
16. Becker BW, Thames AD, Woo E, Castellon SA, Hinkin CH. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav. 2011;15(8):1888–1894.
17. Brega AG, Grigsby J, Kooken R, Hamman RF, Baxter J. The impact of executive cognitive functioning on rates of smoking cessation in the San Luis Valley Health and Aging Study. Age Ageing. 2008;37(5): 521–525.
18. Lenze EJ, Munin MC, Dew MA, et al. Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Int J Geriatr Psychiatry. 2004;19(5):472–478.
19. Cleutjens FA, Wouters EF, Dijkstra JB, et al. The Cognitive-Pulmonary Disease (COgnitive-PD) study: protocol of a longitudinal observational comparative study on neuropsychological functioning of patients with COPD. BMJ open. 2014;4(3):e004495.
20. Global initiative for chronic obstructive lung disease: Pocket guide to COPD diagnosis, management, and prevention. Updated 2015.2015; http://www.goldcopd.org/uploads/users/files/GOLD_Pocket_2015_Feb18.pdf. Accessed August 12, 2016.
21. C.B.S. Standaard Beroepenclassificatie 1992 – editie 2001. Den Haag: SDU; 2001.
22. Luteijn F, Barelds DPF. [Groninger Intelligence Test – 2.Manual]. Groninger Intelligentie Test – 2. Handleiding. Amsterdam, the Netherlands: Pearson Assessment and Information BV; 2004. Dutch.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
24. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1428–1446.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta psychiatr Scand. 1983;67(6):361–370.
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
27. Jolles J, van Boxtel MP, Ponds RW, Metsemakers JF, Houx PJ. De Maastricht Aging Study (MAAS). [The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging].Het longitudinaal perspectief van cognitieve veroudering. Tijdschr Gerontol Geriatr. 1998;29(3):120–129. Dutch.
28. Burgmans S, van Boxtel MP, Smeets F, et al. Prefrontal cortex atrophy predicts dementia over a six-year period. Neurobiol Aging. 2009; 30(9):1413–1419.
29. Singh B, Parsaik AK, Mielke MM, et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clinic Proc. 2013;88(11):1222–1230.
30. Cockrell JR, Folstein MF. Mini-Mental State Examination (MMSE). Psychopharmacol Bull. 1988;24(4):689–692.
31. Dulohery MM, Schroeder DR, Benzo RP. Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life? Int J Chron Obstruct Pulmon Dis. 2015(10): 1883–1889.
32. Dal Negro RW, Bonadiman L, Bricolo FP, Tognella S, Turco P. Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT). Multidiscip Respir Med. 2015;10(1):17.
33. Bucknall CE, Miller G, Lloyd SM, et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ. 2012;344:e1060.
34. Paterniti S, Dufouil C, Bisserbe JC, Alperovitch A. Anxiety, depression, psychotropic drug use and cognitive impairment. Psychol Med. 1999; 29(2):421–428.
35. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care MedS. 2013;187(7):728–735.
36. Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol. 1986;43(1):71–84.
37. Fan VS, Meek PM. Anxiety, depression, and cognitive impairment in patients with chronic respiratory disease. Clin Chest Med. 2014; 35(2):399–409.
38. Lam RW, Kennedy SH, McLntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649–654.
39. Amado-Boccara I, Gougoulis N, Poirier Littré MF, Galinowski A, Loo H. Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev. 1995;19(3):479–493.
40. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14(2):125–130.
41. Friedman NP, Miyake A, Corley RP, Young SE, Defries JC, Hewitt JK. Not all executive functions are related to intelligence. Psychol Sci. 2006;17(2):172–179.
42. Boer LM, Daudey L, Peters JB, Molema J, Prins JB, Vercoulen JH. Assessing the stages of the grieving process in chronic obstructive pulmonary disease (COPD): validation of the Acceptance of Disease and Impairments Questionnaire (ADIQ). Int J Behav Med. 2014;21(3): 561–570.
43. Sulaiman I, Cushen B, Greene G, et al. Objective Assessment of Adherence to Inhalers by COPD Patients. Am J Respir Crit Care Med. 2016 July 13.
44. Finlayson M. Multiple Sclerosis Rehabilitation: From Impairment to Participation. Boca Raton, FL: CRC Press; 2012.
45. Fleming JM, Shum D, Strong J, Lightbody S. Prospective memory rehabilitation for adults with traumatic brain injury: a compensatory training programme. Brain Inj. 2005;19(1):1–10.
46. Merckelbach H, Muris P, Nijman H, de Jong PJ. Self-reported cognitive failures and neurotic symptomatoloy. Pers Indiv Differ. 1996;20(6): 715–724.